Review article: Efficacy and safety of rabeprazole in treating gastroesophageal reflux disease

被引：1
|
作者：
Lim, PWY
Goh, KL
机构：
[1] Eisai Asia Reg Serv Pte Ltd, Singapore 189721, Singapore
[2] Univ Malaya, Kuala Lumpur, Malaysia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2004年 / 19卷
关键词：
gastroesophageal reflux disease; second generation PPI; CYP4502C19 genetic polymorphism; on-demand;
D O I：
10.1111/j.1440-1746.2004.03592.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Proton pump inhibitors (PPI) are the mainstay of gastroesophageal reflux disease (GERD) treatment. They have a good efficacy and short- and long-term safety profile. Rabeprazole is a second generation PPI with rapid onset of action that quickly relieves symptoms of GERD. Rabeprazole consistently and profoundly inhibits gastric acid secretion. Its metabolism is less dependent on CYP4502C19 system and therefore is the least affected among all PPIs by CYP4502C19 genetic polymorphism. Recent studies have also indicated that rabeprazole on-demand is cost effective in preventing non-erosive reflux disease (NERD) symptom relapse.
引用
收藏
页码：S61 / S68
页数：8
相关论文
共 50 条
  • [1] Efficacy of Rabeprazole in the Treatment of Symptomatic Gastroesophageal Reflux Disease
    Peter J. Kahrilas
    Philip Miner
    John Johanson
    Lian Mao
    Leonard Jokubaitis
    Sheldon Sloan
    Digestive Diseases and Sciences, 2005, 50 : 2009 - 2018
  • [2] Efficacy of rabeprazole in the treatment of symptomatic gastroesophageal reflux disease
    Kahrilas, PJ
    Miner, P
    Johanson, J
    Mao, L
    Jokubaitis, L
    Sloan, S
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (11) : 2009 - 2018
  • [3] Efficacy and Safety of Rabeprazole in Children (1-11 Years) With Gastroesophageal Reflux Disease
    Haddad, Ibrahim
    Kierkus, Jaroslaw
    Tron, Eduardo
    Ulmer, April
    Hu, Peter
    Sloan, Sheldon
    Silber, Steven
    Leitz, Gerhard
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2013, 57 (06): : 798 - 807
  • [4] A Comparative Study: Efficacy and Safety of Dexrabeprazole and Rabeprazole in Mild to Moderate Erosive Gastroesophageal Reflux Disease
    Ahmed, S. A. Farook
    Jaida, Jyothirmai
    Palani, Anuradha
    Anandam, B.
    Israel, P. L. John
    INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 : S70 - S70
  • [5] Efficacy of rabeprazole for heartburn and associated symptoms in nonerosive gastroesophageal reflux disease
    Johanson, JF
    Miner, P
    Orr, W
    Jokubaitis, L
    Sloan, S
    GASTROENTEROLOGY, 2002, 122 (04) : A200 - A200
  • [6] An open-label, multicenter study of rabeprazole safety and efficacy for gastroesophageal reflux disease (GERD) in adolescents
    Lu, Yufang
    Gunasekaran, Thirumazhisai
    Haddad, Ibrahim
    Varughese, Shanti
    Kao, Richard
    Thompson, Caroline
    Rossiter, Guillermo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S27 - S27
  • [7] Rabeprazole and esomeprazole in mild-to-moderate erosive gastroesophageal reflux disease: A comparative study of efficacy and safety
    Maiti, Rituparna
    Jaida, Jyothirmai
    Israel, P. L. John
    Koyagura, Narendar
    Mukkisa, Sruthi
    Palani, Anuradha
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2011, 2 (03) : 150 - 157
  • [8] THE COST OF TREATING GASTROESOPHAGEAL REFLUX DISEASE: A SYSTEMATIC REVIEW
    Hoffsten, J.
    Das, S.
    Kartha, M.
    VALUE IN HEALTH, 2023, 26 (12) : S143 - S143
  • [9] A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD)
    Savarino, Edoardo
    Zentilin, Patrizia
    Marabotto, Elisa
    Bodini, Giorgia
    Della Coletta, Marco
    Frazzoni, Marzio
    de Bortoli, Nicola
    Martinucci, Irene
    Tolone, Salvatore
    Pellegatta, Gaia
    Savarino, Vincenzo
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (13) : 1333 - 1343
  • [10] Respiratory physiotherapy in gastroesophageal reflux disease:A review article
    Renata Carvalho de Miranda Chaves
    Tomás Navarro-Rodriguez
    World Journal of Respirology, 2015, (01) : 28 - 33
12345